Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections

被引:97
|
作者
Sprong, Tom
Roos, Dirk
Weemaes, Corry
Neeleman, Chris
Geesing, Christel L. M.
Mollnes, Tom Eirik
van Deuren, Marcel
机构
[1] Univ Nijmegen, Radboud Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Radboud Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Radboud Med Ctr, Dept Intens Care, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Netherlands Blood Transfus Serv, Cent Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands
[7] Bernhoven Hosp, Dept Pediat, Oss, Netherlands
[8] Univ Oslo Hosp, Rikshosp, Inst Immunol, Oslo, Norway
关键词
D O I
10.1182/blood-2005-07-2820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complement system is an essential element in our innate defense against infections with Neisseria meningitidis. We describe 2 cases of meningococcal septic shock, 1 of them fatal, in 2 children of a Turkish family. In the surviving patient, alternative pathway activation was absent and factor D plasma concentrations were undetectable. Concentrations of mannose-binding lectin (MBL), C1q, C4 and C3, factor B, properdin, factor H, and factor I were normal. Mutation analysis of the factor D gene revealed a T638 > G (Val213 > Gly) and a T640 > C (Cys214 > Arg) mutation in the genomic DNA from the patient, both in homozygous form. The consanguineous parents and an unaffected sister had these mutations in heterozygous form. In vitro incubation of factor-D-deficient plasma of the boy with serogroup B N meningitidis showed normal MBL-mediated complement activation but no formation of the alternative pathway C3-convertase C3bBbP, and severely decreased C3bc formation and terminal complement activation. The defect was restored after supplementation with factor D. In conclusion, this is the second report of a factor D gene mutation leading to factor D deficiency in a family with meningococcal disease. This deficiency abolishes alternative-pathway dependent complement activation by N meningitidis, and leads to an increased susceptibility to invasive meningococcal disease.
引用
收藏
页码:4865 / 4870
页数:6
相关论文
共 50 条
  • [41] ACTIVATION OF COMPLEMENT BY ALTERNATIVE PATHWAY AS A FACTOR IN PATHOGENESIS OF PERIODONTAL-DISEASE
    ALLISON, AC
    SCHORLEMMER, HU
    BITTERSUERMANN, D
    LANCET, 1976, 2 (7993): : 1001 - 1004
  • [42] POSSIBLE INVOLVEMENT OF FACTOR-B AND FACTOR-D ZYMOGEN FORMS IN THE ALTERNATIVE PATHWAY ACTIVATION OF HUMAN-COMPLEMENT SYSTEM
    KOZLOV, LV
    SOLYAKOV, LS
    BIOORGANICHESKAYA KHIMIYA, 1982, 8 (03): : 342 - 348
  • [43] FUNCTIONAL DEFICIENCY OF COMPLEMENT FACTOR-D IN A MONOZYGOUS TWIN
    KLUINNELEMANS, HC
    VANVELZENBLAD, H
    VANHELDEN, HPT
    DAHA, MR
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1984, 58 (03): : 724 - 730
  • [44] COMPLEMENT-DEPENDENT ACTIVATION OF PLASMINOGEN BY ACTIVATED FACTOR-B (BB) OF THE ALTERNATIVE PATHWAY OF COMPLEMENT
    SUNDSMO, JS
    WOOD, LM
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 302 - 302
  • [45] MASP1/3 knockout mouse lacks the alternative pathway activation due to deficiency of factor D activation
    Takahashi, Minoru
    Iwaki, Daisuke
    Endo, Yuichi
    Fujita, Teizo
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4103 - 4103
  • [46] ACTIVATION OF HUMAN-COMPLEMENT BY LIPOSOMES - SERUM FACTOR REQUIREMENT FOR ALTERNATIVE PATHWAY ACTIVATION
    MOLD, C
    GEWURZ, H
    JOURNAL OF IMMUNOLOGY, 1980, 125 (02): : 696 - 700
  • [47] INHIBITION OF COMPLEMENT ALTERNATIVE PATHWAY IN MICE WITH FAB ANTIBODY TO RECOMBINANT ADIPSIN FACTOR-D
    PASCUAL, M
    CATANA, E
    WHITE, T
    SPIEGELMAN, BM
    SCHIFFERLI, JA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) : 1389 - 1392
  • [48] Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway
    Karki, Rajeshri G.
    Powers, James
    Mainolfi, Nello
    Anderson, Karen
    Belanger, David B.
    Liu, Donglei
    Ji, Nan
    Jendza, Keith
    Gelin, Christine F.
    Mac Sweeney, Aengus
    Solovay, Catherine
    Delgado, Omar
    Crowley, Maura
    Liao, Sha-Mei
    Argikar, Upendra A.
    Flohr, Stefanie
    La Bonte, Laura R.
    Lorthiois, Edwige L.
    Vulpetti, Anna
    Brown, Ann
    Long, Debby
    Prentiss, Melissa
    Gradoux, Nathalie
    de Erkenez, Andrea
    Cumin, Frederic
    Adams, Christopher
    Jaffee, Bruce
    Mogi, Muneto
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4656 - 4668
  • [49] ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY AND PRODUCTION OF FACTOR-H BY SKELETAL MYOTUBES
    LANG, TJ
    SHIN, ML
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 44 (02) : 185 - 192
  • [50] ACTIVATION OF FACTOR-B OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - ASSESSMENT BY ROCKET IMMUNOELECTROPHORESIS
    KAJDACSYBALLA, A
    DOI, EM
    BAGASRA, O
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (01) : 66 - 73